Background: The peripheral blood is an attractive source of prognostic biomarkers for psychosis conversion. There is limited research on the transcriptomic changes associated with psychosis conversion in the peripheral whole blood.
Study Design: We performed RNA-sequencing of peripheral whole blood from 65 ultra-high-risk (UHR) participants and 70 healthy control participants recruited in the Longitudinal Youth-at-Risk Study (LYRIKS) cohort. 13 UHR participants converted in the study duration. Samples were collected at 3 timepoints, at 12-months interval across a 2-year period. We examined whether the genes differential with psychosis conversion contain schizophrenia risk loci. We then examined the functional ontologies and GWAS associations of the differential genes. We also identified the overlap between differentially expressed genes across different comparisons.
Study Results: Genes containing schizophrenia risk loci were not differentially expressed in the peripheral whole blood in psychosis conversion. The differentially expressed genes in psychosis conversion are enriched for ontologies associated with cellular replication. The differentially expressed genes in psychosis conversion are associated with non-neurological GWAS phenotypes reported to be perturbed in schizophrenia and psychosis but not schizophrenia and psychosis phenotypes themselves. We found minimal overlap between the genes differential with psychosis conversion and the genes that are differential between pre-conversion and non-conversion samples.
Conclusion: The associations between psychosis conversion and peripheral blood-based biomarkers are likely to be indirect. Further studies to elucidate the mechanism behind potential indirect associations are needed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ajp.2023.103796 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Importance of Treatment Modality in Veterans with Opioid Use Disorder: Implications for Virtual Care.
Community Ment Health J
December 2024
Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
This study examined treatment utilization across in-person and virtual treatment modalities in veterans who were on medications for opioid use disorder (MOUD; N = 139). Treatment records for veterans in addiction treatment on MOUD were examined for 3-months prior to telehealth conversions ("Pre-Telehealth," 12/02/2019-03/14/2020), 3-months during the initial telehealth transition ("Telehealth," 03/15/2020-06/30/2020) and 3-months during post-telehealth transition ("Re-Entry," 07/01/2020-10/01/2020). Analyses examined the relationship between treatment modality and demographic features, psychiatric comorbidities, treatment engagement, and illness severity as measured by psychiatric emergency room (PER) utilization.
View Article and Find Full Text PDFPredicting Diagnostic Conversion From Major Depressive Disorder to Bipolar Disorder: An EHR Based Study From Colombia.
Bipolar Disord
December 2024
Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
Objectives: Most bipolar disorder (BD) patients initially present with depressive symptoms, resulting in a delayed diagnosis of BD and poor clinical outcomes. This study aims to identify features predictive of the conversion from Major Depressive Disorder (MDD) to BD by leveraging electronic health record (EHR) data from the Clínica San Juan de Dios Manizales in Colombia.
Methods: We employed a multivariable Cox regression model to identify important predictors of conversion from MDD to BD.
A 2-year longitudinal investigation of insula subregional volumes in early psychosis.
medRxiv
November 2024
Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center.
Background: The insula is a heterogeneous cortical region with three cytoarchitectural subregions-agranular, dysgranular, and granular-that have distinct functional roles. Previous cross-sectional studies have shown smaller volume of all insula subregions in individuals with psychotic disorders. However, longitudinal trajectories of insula subregions in early psychosis, and the relationship between subregional volumes and relevant clinical phenomena, such as perceptual aberrations, have not been previously examined.
View Article and Find Full Text PDFAssociation of abnormal cortical inhibition and clinical outcomes in patients at clinical high risk for psychosis.
Clin Neurophysiol
January 2025
Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address:
Article Synopsis
- Cortical inhibition (CI) abnormalities were investigated in individuals at clinical high risk for psychosis (CHR) using transcranial magnetic stimulation (TMS), comparing them to first-episode schizophrenia (FES) patients and healthy controls (HC).
- Among CHR individuals, those who later developed schizophrenia (CHR-C) exhibited a longer cortical silent period (CSP) compared to healthy controls, while those who did not convert (CHR-NC) had similar CSP levels to HC.
- The study indicates that prolonged CSP in CHR-C patients is linked to poorer neurocognitive performance and suggests CSP may serve as a biomarker for predicting the transition to schizophrenia.
EANM perspective on clinical PET and SPECT imaging in schizophrenia-spectrum disorders: a systematic review of longitudinal studies.
Eur J Nucl Med Mol Imaging
November 2024
Institute of Nuclear Medicine, University College London Hospitals NHS Foundation Trust, London, UK.
Article Synopsis
- Biomarkers in psychiatry are essential for better diagnosis and management, and radionuclide imaging (PET and SPECT) shows potential for practical use, particularly in schizophrenia-spectrum disorders.
- A systematic review evaluated 56 longitudinal studies involving 1,329 patients, focusing on the impact of PET and SPECT imaging on diagnosis and treatment personalization.
- Key findings indicated that PET and SPECT can predict treatment responses and optimize dosages of antipsychotic medications, highlighting the need for more clinical trials to confirm these benefits.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!